Arne Alder

Dr. Arne Alder

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AAArne Alder
Arne Alder
CSCecilia P. Sanchez
Cecilia P. Sanchez
MRMatthew R. G. Russell
Matthew R. G. Russell
LCLucy Collinson
Lucy Collinson
MLMichael Lanzer
Michael Lanzer
JMJoachim M. Matz
Joachim M. Matz
To ensure their survival in the human bloodstream, malaria parasites degrade up to 80% of the host erythrocyte hemoglobin in an acidified digestive vacuole. Here, we combine conditional reverse genetics and quantitative imaging approaches to demonstrate that the human malaria pathogenPlasmodium falciparumemploys a heteromultimeric V-ATPase complex to acidify the digestive vacuole matrix, which is essential for intravacuolar hemoglobin release, heme detoxification, and parasite survival. We reveal an additional function of the membrane-embedded V-ATPase subunits in regulating morphogenesis of the digestive vacuole independent of proton translocation. We further show that intravacuolar accumulation of antimalarial chemotherapeutics is surprisingly resilient to severe deacidification of the vacuole and that modulation of V-ATPase activity does not affect parasite sensitivity toward these drugs.

9 February 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
BLBenjamin Liffner
Benjamin Liffner
JBJuan Miguel Balbin
Juan Miguel Balbin
GSGerald J. Shami
Gerald J. Shami
GSGhizal Siddiqui
Ghizal Siddiqui
JSJan Strauss
Jan Strauss
DWDanny W. Wilson
Danny W. Wilson
Merozoite invasion of host red blood cells (RBCs) is essential for survival of the human malaria parasite Plasmodium falciparum. Proteins involved with RBC binding and invasion are secreted from dual-club shaped organelles at the apical tip of the merozoite called the rhoptries. Here we characterise P. falciparum Cytosolically Exposed Rhoptry Leaflet Interacting protein 2 (PfCERLI2), as a rhoptry bulb protein that is essential for merozoite invasion. Phylogenetic analyses show that cerli2 arose through an ancestral gene duplication of cerli1. We show that PfCERLI2 is essential for blood-stage growth and localises to the cytosolic face of the rhoptry bulb. Inducible knockdown of PfCERLI2 led to a proportion of merozoites failing to invade and was associated with elongation of the rhoptry organelle during merozoite development and inhibition of rhoptry antigen processing. These findings identify PfCERLI2 as a protein that has key roles in rhoptry biology during merozoite invasion.

26 April 2022 in mBio
Verified
Journal Article
Open access
JWJan Stephan Wichers
Jan Stephan Wichers
PMPaolo Mesén-Ramírez
Paolo Mesén-Ramírez
GFGwendolin Fuchs
Gwendolin Fuchs
JYJing Yu-Strzelczyk
Jing Yu-Strzelczyk
JSJan Stäcker
Jan Stäcker
JSJan Strauss
Jan Strauss
Plasmodium falciparum -infected erythrocytes possess multiple compartments with designated membranes. Transporter proteins embedded in these membranes not only facilitate movement of nutrients, metabolites, and other molecules between these compartments, but also are common therapeutic targets and can confer antimalarial drug resistance.

13 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SSSandra Isabel Schweda
Sandra Isabel Schweda
AAArne Alder
Arne Alder
TGTim Gilberger
Tim Gilberger
CKConrad Kunick
Conrad Kunick
Malaria causes hundreds of thousands of deaths every year, making it one of the most dangerous infectious diseases worldwide. Because the pathogens have developed resistance against most of the established anti-malarial drugs, new antiplasmodial agents are urgently needed. In analogy to similar antiplasmodial ketones, 4-arylthieno[2,3-b]pyridine-2-carboxamides were synthesized by Thorpe-Ziegler reactions. In contrast to the related ketones, these carboxamides are only weak inhibitors of the plasmodial enzyme PfGSK-3 but the compounds nevertheless show strong antiparasitic activity. The most potent representatives inhibit the pathogens with IC50 values in the two-digit nanomolar range and exhibit high selectivity indices (>100).

10 August 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AAArne Alder
Arne Alder
LWLouisa Wilcke
Louisa Wilcke
EPEmma Pietsch
Emma Pietsch
HTHeidrun von Thien
Heidrun von Thien
SPSamuel Pazicky
Samuel Pazicky
TGTim-Wolf Gilberger
Tim-Wolf Gilberger
Malaria is responsible for hundreds of thousands of deaths every year. The lack of an effective vaccine and the global spread of multidrug resistant parasites hampers the fight against the disease and underlines the need for new antimalarial drugs. Central to the pathogenesis of malaria is the proliferation of Plasmodium parasites within human erythrocytes. Parasites invade erythrocytes via a coordinated sequence of receptor–ligand interactions between the parasite and the host cell. Posttranslational modifications such as protein phosphorylation are known to be key regulators in this process and are mediated by protein kinases. For several parasite kinases, including the Plasmodium falciparum glycogen synthase kinase 3 (PfGSK3), inhibitors have been shown to block erythrocyte invasion. Here, we provide an assessment of PfGSK3 function by reverse genetics. Using targeted gene disruption, we show the active gene copy, PfGSK3β, is not essential for asexual blood stage proliferation, although it modulates efficient erythrocyte invasion. We found functional inactivation leads to a 69% decreased growth rate and confirmed this growth defect by rescue experiments with wildtype and catalytically inactive mutants. Functional knockout of PfGSK3β does not lead to transcriptional upregulation of the second copy of PfGSK3. We further analyze expression, localization, and function of PfGSK3β during gametocytogenesis using a parasite line allowing conditional induction of sexual commitment. We demonstrate PfGSK3β-deficient gametocytes show a strikingly malformed morphology leading to the death of parasites in later stages of gametocyte development. Taken together, these findings are important for our understanding and the development of PfGSK3 as an antimalarial target.

5 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DLDuc Hoàng Lande
Duc Hoàng Lande
ANAbedelmajeed Nasereddin
Abedelmajeed Nasereddin
AAArne Alder
Arne Alder
TGTim W. Gilberger
Tim W. Gilberger
RDRon Dzikowski
Ron Dzikowski
CKConrad Kunick
Conrad Kunick
Malaria is one of the most dangerous infectious diseases. Because the causative Plasmodium parasites have developed resistances against virtually all established antimalarial drugs, novel antiplasmodial agents are required. In order to target plasmodial kinases, novel N-unsubstituted bisindolylcyclobutenediones were designed as analogs to the kinase inhibitory bisindolylmaleimides. Molecular docking experiments produced favorable poses of the unsubstituted bisindolylcyclobutenedione in the ATP binding pocket of various plasmodial protein kinases. The synthesis of the title compounds was accomplished by sequential Friedel-Crafts acylation procedures. In vitro screening of the new compounds against transgenic NF54-luc P. falciparum parasites revealed a set of derivatives with submicromolar activity, of which some displayed a reasonable selectivity profile against a human cell line. Although the molecular docking studies suggested the plasmodial protein kinase PfGSK-3 as the putative biological target, the title compounds failed to inhibit the isolated enzyme in vitro. As selective submicromolar antiplasmodial agents, the N-unsubstituted bisindolylcyclobutenediones are promising starting structures in the search for antimalarial drugs, albeit for a rational development, the biological target addressed by these compounds has yet to be identified.